MAPT and Alzheimer disease: In a 1562 case study, Nho K measured 20 kinds of primary and secondary BAs metabolites at the serum level, which were found to be related with amyloid proteins and tau in the cerebrospinal fluid of AD patients, as well as with brain atrophy and cerebral glucose metabolism dysfunction, thus providing further support for the role of this pathway in AD pathophysiology [53].